Second generation sequencing of the mesothelioma tumor genome.

The current paradigm for elucidating the molecular etiology of cancers relies on the interrogation of small numbers of genes, which limits the scope of investigation. Emerging second-generation massively parallel DNA sequencing technologies have enabled more precise definition of the cancer genome o...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Raphael Bueno, Assunta De Rienzo, Lingsheng Dong, Gavin J Gordon, Colin F Hercus, William G Richards, Roderick V Jensen, Arif Anwar, Gautam Maulik, Lucian R Chirieac, Kim-Fong Ho, Bruce E Taillon, Cynthia L Turcotte, Robert G Hercus, Steven R Gullans, David J Sugarbaker
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2010
Materias:
R
Q
Acceso en línea:https://doaj.org/article/091c3372829c4d0793ec38e8d8e5b809
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:091c3372829c4d0793ec38e8d8e5b809
record_format dspace
spelling oai:doaj.org-article:091c3372829c4d0793ec38e8d8e5b8092021-12-02T20:21:43ZSecond generation sequencing of the mesothelioma tumor genome.1932-620310.1371/journal.pone.0010612https://doaj.org/article/091c3372829c4d0793ec38e8d8e5b8092010-05-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20485525/pdf/?tool=EBIhttps://doaj.org/toc/1932-6203The current paradigm for elucidating the molecular etiology of cancers relies on the interrogation of small numbers of genes, which limits the scope of investigation. Emerging second-generation massively parallel DNA sequencing technologies have enabled more precise definition of the cancer genome on a global scale. We examined the genome of a human primary malignant pleural mesothelioma (MPM) tumor and matched normal tissue by using a combination of sequencing-by-synthesis and pyrosequencing methodologies to a 9.6X depth of coverage. Read density analysis uncovered significant aneuploidy and numerous rearrangements. Method-dependent informatics rules, which combined the results of different sequencing platforms, were developed to identify and validate candidate mutations of multiple types. Many more tumor-specific rearrangements than point mutations were uncovered at this depth of sequencing, resulting in novel, large-scale, inter- and intra-chromosomal deletions, inversions, and translocations. Nearly all candidate point mutations appeared to be previously unknown SNPs. Thirty tumor-specific fusions/translocations were independently validated with PCR and Sanger sequencing. Of these, 15 represented disrupted gene-encoding regions, including kinases, transcription factors, and growth factors. One large deletion in DPP10 resulted in altered transcription and expression of DPP10 transcripts in a set of 53 additional MPM tumors correlated with survival. Additionally, three point mutations were observed in the coding regions of NKX6-2, a transcription regulator, and NFRKB, a DNA-binding protein involved in modulating NFKB1. Several regions containing genes such as PCBD2 and DHFR, which are involved in growth factor signaling and nucleotide synthesis, respectively, were selectively amplified in the tumor. Second-generation sequencing uncovered all types of mutations in this MPM tumor, with DNA rearrangements representing the dominant type.Raphael BuenoAssunta De RienzoLingsheng DongGavin J GordonColin F HercusWilliam G RichardsRoderick V JensenArif AnwarGautam MaulikLucian R ChirieacKim-Fong HoBruce E TaillonCynthia L TurcotteRobert G HercusSteven R GullansDavid J SugarbakerPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 5, Iss 5, p e10612 (2010)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Raphael Bueno
Assunta De Rienzo
Lingsheng Dong
Gavin J Gordon
Colin F Hercus
William G Richards
Roderick V Jensen
Arif Anwar
Gautam Maulik
Lucian R Chirieac
Kim-Fong Ho
Bruce E Taillon
Cynthia L Turcotte
Robert G Hercus
Steven R Gullans
David J Sugarbaker
Second generation sequencing of the mesothelioma tumor genome.
description The current paradigm for elucidating the molecular etiology of cancers relies on the interrogation of small numbers of genes, which limits the scope of investigation. Emerging second-generation massively parallel DNA sequencing technologies have enabled more precise definition of the cancer genome on a global scale. We examined the genome of a human primary malignant pleural mesothelioma (MPM) tumor and matched normal tissue by using a combination of sequencing-by-synthesis and pyrosequencing methodologies to a 9.6X depth of coverage. Read density analysis uncovered significant aneuploidy and numerous rearrangements. Method-dependent informatics rules, which combined the results of different sequencing platforms, were developed to identify and validate candidate mutations of multiple types. Many more tumor-specific rearrangements than point mutations were uncovered at this depth of sequencing, resulting in novel, large-scale, inter- and intra-chromosomal deletions, inversions, and translocations. Nearly all candidate point mutations appeared to be previously unknown SNPs. Thirty tumor-specific fusions/translocations were independently validated with PCR and Sanger sequencing. Of these, 15 represented disrupted gene-encoding regions, including kinases, transcription factors, and growth factors. One large deletion in DPP10 resulted in altered transcription and expression of DPP10 transcripts in a set of 53 additional MPM tumors correlated with survival. Additionally, three point mutations were observed in the coding regions of NKX6-2, a transcription regulator, and NFRKB, a DNA-binding protein involved in modulating NFKB1. Several regions containing genes such as PCBD2 and DHFR, which are involved in growth factor signaling and nucleotide synthesis, respectively, were selectively amplified in the tumor. Second-generation sequencing uncovered all types of mutations in this MPM tumor, with DNA rearrangements representing the dominant type.
format article
author Raphael Bueno
Assunta De Rienzo
Lingsheng Dong
Gavin J Gordon
Colin F Hercus
William G Richards
Roderick V Jensen
Arif Anwar
Gautam Maulik
Lucian R Chirieac
Kim-Fong Ho
Bruce E Taillon
Cynthia L Turcotte
Robert G Hercus
Steven R Gullans
David J Sugarbaker
author_facet Raphael Bueno
Assunta De Rienzo
Lingsheng Dong
Gavin J Gordon
Colin F Hercus
William G Richards
Roderick V Jensen
Arif Anwar
Gautam Maulik
Lucian R Chirieac
Kim-Fong Ho
Bruce E Taillon
Cynthia L Turcotte
Robert G Hercus
Steven R Gullans
David J Sugarbaker
author_sort Raphael Bueno
title Second generation sequencing of the mesothelioma tumor genome.
title_short Second generation sequencing of the mesothelioma tumor genome.
title_full Second generation sequencing of the mesothelioma tumor genome.
title_fullStr Second generation sequencing of the mesothelioma tumor genome.
title_full_unstemmed Second generation sequencing of the mesothelioma tumor genome.
title_sort second generation sequencing of the mesothelioma tumor genome.
publisher Public Library of Science (PLoS)
publishDate 2010
url https://doaj.org/article/091c3372829c4d0793ec38e8d8e5b809
work_keys_str_mv AT raphaelbueno secondgenerationsequencingofthemesotheliomatumorgenome
AT assuntaderienzo secondgenerationsequencingofthemesotheliomatumorgenome
AT lingshengdong secondgenerationsequencingofthemesotheliomatumorgenome
AT gavinjgordon secondgenerationsequencingofthemesotheliomatumorgenome
AT colinfhercus secondgenerationsequencingofthemesotheliomatumorgenome
AT williamgrichards secondgenerationsequencingofthemesotheliomatumorgenome
AT roderickvjensen secondgenerationsequencingofthemesotheliomatumorgenome
AT arifanwar secondgenerationsequencingofthemesotheliomatumorgenome
AT gautammaulik secondgenerationsequencingofthemesotheliomatumorgenome
AT lucianrchirieac secondgenerationsequencingofthemesotheliomatumorgenome
AT kimfongho secondgenerationsequencingofthemesotheliomatumorgenome
AT bruceetaillon secondgenerationsequencingofthemesotheliomatumorgenome
AT cynthialturcotte secondgenerationsequencingofthemesotheliomatumorgenome
AT robertghercus secondgenerationsequencingofthemesotheliomatumorgenome
AT stevenrgullans secondgenerationsequencingofthemesotheliomatumorgenome
AT davidjsugarbaker secondgenerationsequencingofthemesotheliomatumorgenome
_version_ 1718374089564880896